- Canopy Growth Corporation recently announced that its DOJA facility in Kelowna, British Columbia, has been repurposed to exclusively cultivate small-batch craft cannabis specifically for Spectrum Therapeutics’ medical patients, including Canada’s veteran community.
- This shift highlights Canopy Growth’s renewed emphasis on quality-focused, medical cannabis production, a move that tailors the site’s output exclusively to registered patients and strengthens its position within the Canadian medical cannabis sector.
- We’ll now examine how the focus on exclusive medical craft cannabis production at DOJA could influence Canopy Growth’s future outlook.
Trump has pledged to “unleash” American oil and gas and these 22 US stocks have developments that are poised to benefit.
Canopy Growth Investment Narrative Recap
Owning shares in Canopy Growth means believing in the long-term potential of the global medical cannabis market and the…
